SEC Form D filing

Immunis, Inc., 2026-06-15

An SEC Form D private-offering notice from Irvine, CA, a $11,975,000 filer-stated offering target in Biotech. Filed 2026-06-15. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Immunis, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing stem cell derived secretome biologics to treat age related muscle and immune decline

Filed 2026-06-15Filed to raise $11,975,000First money in 2026-05-28Raised so far $11,975,000HQ (as filed) Irvine, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified immunisbiomedical.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source